Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

251 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: rationale and design of phase I/II trials.
Guilhot F, Gardembas M, Rousselot P, Tulliez M, Vigier M, Buzyn A, Rigal-Huguet F, Legros L, Michallet M, Berthou C, Najman A, Maloisel F, Mahon FX, Facon T, Berthaud P, Guilhot J; CML French Group. Guilhot F, et al. Among authors: Najman A. Semin Hematol. 2003 Apr;40(2 Suppl 2):92-7. doi: 10.1053/shem.2003.50048. Semin Hematol. 2003. PMID: 12783382 Review.
A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant.
Laporte JP, Yeshurun M, Fouillard L, Labopin M, Cailliot C, Lesage S, Isnard F, Najman A, Gorin NC. Laporte JP, et al. Among authors: Najman A. Leukemia. 2004 Oct;18(10):1717-21. doi: 10.1038/sj.leu.2403427. Leukemia. 2004. PMID: 15295607
Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.
Gorin NC, Labopin M, Laporte JP, Douay L, Lopez M, Lesage S, Fouillard L, Isnard F, Jouet JP, Bellal N, Perot C, Van Den Akker J, Bauters F, Najman A. Gorin NC, et al. Among authors: Najman A. Exp Hematol. 1999 Dec;27(12):1822-30. doi: 10.1016/s0301-472x(99)00121-6. Exp Hematol. 1999. PMID: 10641600
Thymosin beta4, inhibitor for normal hematopoietic progenitor cells.
Bonnet D, Lemoine FM, Frobert Y, Bonnet ML, Baillou C, Najman A, Guigon M. Bonnet D, et al. Among authors: Najman A. Exp Hematol. 1996 Jun;24(7):776-82. Exp Hematol. 1996. PMID: 8647227
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group.
Guilhot F, Guerci A, Fiere D, Harousseau JL, Maloisel F, Bouabdallah R, Guyotat D, Rochant H, Najman A, Nicolini F, Colombat P, Abgrall JF, Ifrah N, Brière J, Bauters F, Navarro M, Morice P, Bordessoule D, Vilque JP, Desablens B, Tertian G, Blanc M, Chastang C, Tanzer J. Guilhot F, et al. Among authors: Najman A. Bone Marrow Transplant. 1996 May;17 Suppl 3:S29-31. Bone Marrow Transplant. 1996. PMID: 8769697 Clinical Trial. No abstract available.
251 results
Jump to page
Feedback